Bristow D R, Martin I L
MRC Molecular Neurobiology Unit, University of Cambridge Medical School, England.
J Neurochem. 1987 Nov;49(5):1386-93. doi: 10.1111/j.1471-4159.1987.tb01004.x.
We have solubilised the gamma-aminobutyric acid/benzodiazepine (GABA/BDZ) receptor from rat cerebellum using 3-[(3-cholamidopropyl)dimethylammonio] 1-propane sulphonate (CHAPS) in the presence of a natural brain lipid extract and cholesteryl hemisuccinate. The soluble material shows a homogeneous [3H]flunitrazepam ([3H]FNZ) binding population with an equilibrium dissociation constant (KD) of 4.4 +/- 0.2 nM compared to a KD of 2.3 +/- 0.2 nM in cerebellar synaptosomal membranes. The receptor complex in solution retains the characteristic facilitation of [3H]flunitrazepam binding induced by GABA, the pyrazolopyridine cartazolate, and the depressant barbiturate pentobarbital to the same extent as that observed in synaptosomal membranes. Furthermore, these responses are retained both quantitatively and qualitatively when this preparation is stored for 48 h at 4 degrees C. This is contrary to the results obtained with a CHAPS-soluble preparation including asolectin in which these responses are anomalous and extremely labile on storage.
我们在天然脑脂质提取物和半琥珀酸胆固醇存在的情况下,使用3-[(3-胆酰胺丙基)二甲基铵]1-丙烷磺酸盐(CHAPS)从大鼠小脑中溶解了γ-氨基丁酸/苯二氮䓬(GABA/BDZ)受体。与小脑突触体膜中2.3±0.2 nM的平衡解离常数(KD)相比,可溶性物质显示出均一的[³H]氟硝西泮([³H]FNZ)结合群体,其KD为4.4±0.2 nM。溶液中的受体复合物保留了GABA、吡唑并吡啶卡他唑和抑制性巴比妥类药物戊巴比妥诱导的[³H]氟硝西泮结合的特征性促进作用,其程度与突触体膜中观察到的相同。此外,当该制剂在4℃下储存48小时时,这些反应在数量和质量上均得以保留。这与用包含大豆卵磷脂的CHAPS可溶性制剂获得的结果相反,在该制剂中这些反应异常且在储存时极其不稳定。